4893 items matching your search terms.

Effect of periodontal therapy on arterial structure and function among Aboriginal Australians: a randomized, controlled trial

Kapellas, K. Maple-Brown, L. J. Jamieson, L. M. Do, L. G. O'Dea, K. Brown, A. Cai, T. Y. Anstey, N. M. Sullivan, D. R. Wang, H. Celermajer, D. S. Slade, G. D. Skilton, M. R.
HYPERTENSION, 2014     DOI:10.1161/​HYPERTENSIONAHA.114.03359

PIK3CA, BRAF and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer—results from NCIC CTG/AGITG CO.17

Karapetis, C. S. Jonker, D. Daneshmand, M. Hanson, J. E. O'Callaghan, C. J. Marginean, C. Zalcberg, J. R. Simes, J. Moore, M. J. Tebbutt, N. C. Price, T. J. Shapiro, J. D. Pavlakis, N. Gibbs, P. Van Hazel, G. A. Lee, U. Haq, R. Virk, S. Tu, D. Lorimer, I. A.
CLINICAL CANCER RESEARCH, 2014     DOI:10.1158/1078-0432

The rising cost of anti-cancer drugs

Karikios, D. J. Schofield, D. Salkeld, G. Mann, K. P. Trotman, J. Stockler, M.
, 2014     DOI:http://dx.doi.org/10.1016/j.ejca.2014.03.136

The rising cost of anticancer drugs in Australia

Karikios, D.J. Schofield, D. Salkeld, G. Mann, K.P. Trotman, J. Stockler, M.
INTERNAL MEDICINE JOURNAL, 2014     DOI:10.1111/imj.12399

Recent clinical trials on lipid lowering treatment

Keech, A

Risk factors and prevention

Keech, A

About randomised trials related to lipoproteins in diabetes mellitus

Keech, A. Jenkins, A. Gebski, V.
, 2014     DOI:10.1007/978-1-4614-7554-5_17

Antiangiogenic therapy for high-grade glioma

Khasraw, M. Ameratunga, M.S. Grant, R. Wheeler, H. Pavlakis, N.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014     DOI:10.1002/14651858.CD008218.pub3

Poly(ADP-ribose) polymerase inhibitors for locally advanced or metastatic breast cancer

Khasraw, M. Patil Sujata, M. Traina Tiffany, A. Robson Mark, E.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014     DOI:10.1002/14651858.CD011395

Accuracy of oncologists’ estimates of survival time for patients with advanced non-small-cell lung cancer

Kiely, BE Veillard, AS Davidson, JA Briscoe, KP Hughes, BGM Begbie, S Pavlakis, N Millward, M Boyer, M Brown, C Muljadi, N Coskinas, X Stockler, M

How long have I got? Attitudes of patients to receiving survival information formatted as three scenarios

Kiely, B.E. Martin, A Grimison, P Chantrill, L Tattersall, M.H.N. Blinman, P Muljadi, N Stockler, M

Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer

King, M. T. Stockler, M. R. Butow, P. O'Connell, R. Voysey, M. Oza, A. M. Gillies, K. Donovan, H. S. Mercieca-Bebber, R. Martyn, J. Sjoquist, K. Friedlander, M. L.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014     DOI:10.1097/IGC.0000000000000167

A new patient-reported outcome measure for symptom benefit with chemotherapy: the Measure of Ovarian Symptoms and Treatment concerns (MOST)

King, M. T. Stockler, M. R. Butow, P. O'Connell, R. Voysey, M. Oza, A. M. Gillies, K. Donovan, H. S. Mercieca-Bebber, R. Martyn, J. Sjoquist, K. Friedlander, M. L.

Activity and reporting characteristics of clinical practice guideline implementation trials registered on the ANZCTR

Ko, H. Hunter, K. Askie, L.

Trends in clinical trial activity in Australia from 2005 to 2013. Implications for health research trade and ethics

Ko, H. Hunter, K. Askie, L.